- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Rad Laboratories Class B (BIOb)
Bio-Rad Laboratories Class B stock price live, this page displays NYSE BIOb stock exchange data. View the BIOb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bio-Rad Laboratories Class B real time stock price chart below.
What Is the Bio-Rad Laboratories Class B Stock Price Today?
The Bio-Rad Laboratories Class B stock price today is 379.50.
What Is the Stock Symbol for Bio-Rad Laboratories Class B?
The stock symbol for Bio-Rad Laboratories Class B is "BIOb."
What Stock Exchange Does Bio-Rad Laboratories Class B Trade On?
Bio-Rad Laboratories Class B is listed and trades on the NYSE stock exchange.
Is Bio-Rad Laboratories Class B a Good Stock to Buy?
Determining whether Bio-Rad Laboratories Class B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOb quote. (ISIN: US0905721082)
What Is the Bio-Rad Laboratories Class B Stock Price Today?
The Bio-Rad Laboratories Class B stock price today is 379.50.
What Is the Stock Symbol for Bio-Rad Laboratories Class B?
The stock symbol for Bio-Rad Laboratories Class B is "BIOb."
What Stock Exchange Does Bio-Rad Laboratories Class B Trade On?
Bio-Rad Laboratories Class B is listed and trades on the NYSE stock exchange.
Is Bio-Rad Laboratories Class B a Good Stock to Buy?
Determining whether Bio-Rad Laboratories Class B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOb quote. (ISIN: US0905721082)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
379.50
379.50
52 wk Range
243.84
401.59
BIOb is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
379.50379.50
52 wk Range
243.84401.59
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIOb Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Nov 04, 2026
EPS / Forecast
2.65 / 2.23
Revenue / Forecast
656.4M / 649.94M
Compare BIOb to Peers and Sector
Metrics to compare | BIOb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIObPeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.0x | 27.3x | −0.2x | |
PEG Ratio | 0.04 | −1.29 | 0.00 | |
Price/Book | 1.3x | 3.0x | 2.6x | |
Price / LTM Sales | 4.0x | 2.8x | 2.8x | |
Upside (Analyst Target) | - | −2.6% | 65.6% | |
Fair Value Upside | Unlock | 0.7% | 10.0% | Unlock |
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bio Rad B (BIOb) Stock Price Today?
The Bio Rad B stock price today is 379.50 USD.
What Stock Exchange Does Bio Rad B Trade On?
Bio Rad B is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Bio Rad B?
The stock symbol for Bio Rad B is "BIOb."
What Is the Bio Rad B Market Cap?
As of today, Bio Rad B market cap is 9.98B USD.
What Is Bio Rad B's Earnings Per Share (TTM)?
The Bio Rad B EPS (TTM) is 38.05.
When Is the Next Bio Rad B Earnings Date?
Bio Rad B will release its next earnings report on Feb 18, 2027.
From a Technical Analysis Perspective, Is BIOb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bio Rad B Stock Split?
Bio Rad B has split 9 times.
How Many Employees Does Bio Rad B Have?
Bio Rad B has 7450 employees.
What is the current trading status of Bio Rad B (BIOb)?
As of Nov 07, 2026, Bio Rad B (BIOb) is trading at a price of 379.50 USD, with a previous close of 379.50 USD. The stock has fluctuated within a day range of 379.50 USD to 379.50 USD, while its 52-week range spans from 243.84 USD to 401.59 USD.
What Is the BIOb After Hours Price?
BIOb's last after hours stock price is 371.91 USD, the stock has decreased by -7.59, or -2.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.